Were Methamphetamine-Associated PAH Patients Hemodynamically Worse Than Idiopathic PAH Patients?

A U.S. PAH Biobank analysis compared people classified with methamphetamine-associated pulmonary arterial hypertension (MA-PAH) with two other pulmonary arterial hypertension groups. Of 1,830 patients, 42 had MA-PAH, 1,073 had idiopathic PAH and 715 had connective-tissue-associated PAH.

What differed by comparison group

Mean pulmonary artery pressure and pulmonary vascular resistance in the MA-PAH group were similar to the idiopathic group, but higher than the connective-tissue-associated group. The authors did not detect a statistically significant difference in functional class among the three groups, and percent-predicted six-minute walking distance was comparable.

Why this is not an individual causation test

The study describes people already enrolled with PAH and compares group characteristics. It does not estimate the chance that a particular methamphetamine user will develop PAH, and the MA-PAH subgroup was small. Similarity to one comparison group does not imply identical disease mechanisms, prognosis or treatment response. The clinical label and the registry data should not replace a patient-specific exposure history and diagnostic assessment.

The supported conclusion is that hemodynamic severity in this registry sample depended on the comparison group: similar to idiopathic PAH on selected measures, higher than connective-tissue-associated PAH on others.

Source: Charoenpong P, et al. Methamphetamine-associated pulmonary arterial hypertension: data from the PAH Biobank. BMJ Open Respiratory Research. 2023;10:e001917. doi:10.1136/bmjresp-2023-001917.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Did Cebranopadol Lower Cocaine-Induced Hyperactivity in Rats?

A rat study tested whether cebranopadol, a candidate previously studied for effects on cocaine seeking, altered cocaine pharmacokinetics or movement. Those are separate questions: a drug can change behavior without changing how much cocaine circulates. The measured results Cebranopadol did not significantly change cocaine pharmacokinetics in the study. At doses…

Spread the love

Read Article: Did Cebranopadol Lower Cocaine-Induced Hyperactivity in Rats?

Did MDMA and Methamphetamine Change Early Face Processing the Same Way?

MDMA and methamphetamine are both stimulants, but they did not produce the same EEG finding in a study of emotional-face viewing. Investigators measured early visual responses while participants saw happy, angry and neutral faces in an oddball task. The selective result MDMA enhanced the N170 component for happy and angry…

Spread the love

Read Article: Did MDMA and Methamphetamine Change Early Face Processing the Same Way?

Were Methamphetamine-Associated PAH Patients Hemodynamically Worse Than Idiopathic PAH Patients?

A U.S. PAH Biobank analysis compared people classified with methamphetamine-associated pulmonary arterial hypertension (MA-PAH) with two other pulmonary arterial hypertension groups. Of 1,830 patients, 42 had MA-PAH, 1,073 had idiopathic PAH and 715 had connective-tissue-associated PAH. What differed by comparison group Mean pulmonary artery pressure and pulmonary vascular resistance in…

Spread the love

Read Article: Were Methamphetamine-Associated PAH Patients Hemodynamically Worse Than Idiopathic PAH Patients?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us